SCHEMBL31337804

SCHEMBL31337804

CCOC(=O)c1cccc(N2CCC(F)(F)CC2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
MAPT P10636 1/20 0.47
CRBN Q96SW2 1/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
KDM4E B2RXH2 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
KMT2A Q03164 1/20 0.44
GAA P10253 1/20 0.42
ACACB O00763 1/20 0.42
KIF18A Q8NI77 1/20 0.42
HRH3 Q9Y5N1 2/20 0.41
OGA O60502 1/20 0.41
HSD11B1 P28845 2/20 0.40
PTGER4 P35408 1/20 0.40
NAPEPLD Q6IQ20 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
JAK2 O60674 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22304530 0.84 CYP1A2 (0.52) CYP1A2MAPTCRBNNPC1RAB9A
SCHEMBL21875248 0.84 CYP1A2 (0.62) CYP1A2MAPTNPC1RAB9AKDM4E
SCHEMBL28534611 0.83 CYP1A2 (0.60) CYP1A2MAPTNPC1RAB9AKDM4E
SCHEMBL6967592 0.82 CYP1A2 (0.59) CYP1A2MAPTCRBNNPC1RAB9A
SCHEMBL2810512 0.82 CYP1A2 (0.59) CYP1A2MAPTNPC1RAB9AKDM4E
SCHEMBL26617961 0.81 ACACB (0.46) CRBNACACBKIF18AHSD11B1PTGER4
SCHEMBL441409 0.81 CYP1A2 (0.57) CYP1A2MAPTNPC1RAB9AKDM4E
Hydrochloric Acid SCHEMBL445411 0.81 CYP1A2 (0.57) CYP1A2MAPTCRBNNPC1RAB9A
SCHEMBL6945432 0.80 CYP1A2 (0.56) CYP1A2MAPTNPC1RAB9AKDM4E
SCHEMBL26618183 0.79 KIF18A (0.44) CRBNACACBKIF18AHSD11B1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025020624-A1 BENZENE RING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE 捷思英达控股有限公司 2025-01-30 WO disclosed